CB Rank (Person) 87,883
  • Gender Male

Managing & Scientific Director, ABA BioResearch; Fifteen years of experience in CRO (pharmacology and toxicology); twenty years bioregulatory consulting; Faculty of Medicine, McGill University; Board member, Mount Sinai Hospital Corporation; Special Advisor, Centre for Translational Research in Cancer R&D, Jewish General Hospital (McGill

University); Senior advisor at NGN Capital. Several board seats, public & private and Scientific Advisory Boards.

Number of Current Jobs 1
Colin Bier is the President, CEO at PIN Pharma.
There is no recent news or activity for this profile.